Search News Archives
Follow us on
Conferences | Events

Media Partners

 

OGT to be Acquired by Sysmex Corporation a Leading Provider of Haematology and In Vitro Diagnostics Products

publication date: Jun 27, 2017
 | 
author/source: Oxford Gene Technology

Oxford Gene Technology (OGT), The Molecular Genetics Company, have announced that it has signed an agreement to be acquired by Sysmex Corporation (Sysmex), a Japanese in vitro diagnostic company.

OGTSysmex will acquire all of OGT’s shares, gaining access to OGT’s genetic analysis technologies and expertise in the cytogenetics domain. OGT will become a wholly owned subsidiary of Sysmex. Further terms of the agreement are not being disclosed.

Sysmex develops, produces and sells integrated instruments, reagents and software used in in vitro diagnostics and is the leading supplier globally in haematology, haemostasis and urinanalysis. The acquisition of OGT will allow Sysmex to enter the cytogenetics market with FISH (fluorescence in situ hybridisation) and aCGH (array comparative genomic hybridisation) products. It will also strengthen its technology base in molecular genetics through OGT’s NGS (next generation sequencing) reagent development capabilities. The acquisition of OGT expands Sysmex’s life science business and reinforces its initiatives towards personalised medicine.

For the year ended 30 September 2016 OGT recorded sales of £19.7m primarily from its fully integrated molecular genetics product portfolio of Cytocell® FISH probes, SureSeq™ NGS products and CytoSure™ microarray products that together grew by 30% in FY16. The sustained profitable growth in rapidly expanding markets along with OGT’s strong heritage in hybridisation-based technologies positions it well for the future in the field of molecular medicine and the acquisition by Sysmex serves to further strengthen this position.

Professor Sir Edwin Southern, founder of OGT comments “We are delighted to become part of such a well-regarded organisation and truly believe that the opportunities arising from joining a large global corporation like Sysmex will be transformational for OGT, its employees and customers”.

Several product development synergies have been identified that combine OGT’s innovation and expertise in genetic assays for haematology, solid cancer and rare disease with Sysmex’s expertise in instrument development and in vitro diagnostics to expand offerings in genomic medicine. For example, R&D teams from OGT and Sysmex will collaborate to develop an automated system for FISH testing by combining Sysmex’s automation technology with the high-quality FISH reagent development expertise OGT possesses.

In addition, adding OGT’s array CGH and NGS capabilities will expand opportunities further in genetic testing in the field of rare diseases and liquid biopsies.

OGT’s CEO Dr Mike Evans adds, “Alongside the exciting product development opportunities already identified, there are a number of beneficial commercial synergies that will expand market access for OGT’s products putting us at the forefront of molecular genetics. We are looking forward to the next chapter in our development as part of Sysmex”.


more about OGT


more news from OGT


 


If you have not logged into the website then please enter your details below.



 


Popular this Month

 

Win a PIPETBOY from the new Integra summer collection!

 

Great Savings off Selected GC Columns

 

CytoSMART raises 5.2 million Euros for further product innovation and growth

 

High Volume Sample Storage in Space Efficient 96-Well Format

 

Cherwell Publishes Guide on Sterility Testing

 

Effective Removal of DMSO from Stored Samples

 

ATL Webcast: A Practical Guide to Selecting the Right LIMS

 

Genetic study reveals how gut bacteria work to keep us healthy

 

Lonza Establishes Custom Cell Biology Services to Offer Unique Manufacturing and Testing Capabilities

 

Thermo Fisher Scientific Opens Food Safety Customer Solution Center in India

 

 


 

 


 

Can't find what you are looking for?

Search by company or by product


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd